Literature DB >> 24846966

[The application of next generation sequencing on epigenetic study].

Sheng Shen1, Yanchun Qu1, Jun Zhang1.   

Abstract

The application of next generation sequencing (NGS) technique has a great impact on epigenetic studies. Coupled with NGS, a number of sequencing-based methodologies have been developed and applied in epigenetic studies, such as Whole Genome Bisulfite Sequencing (WGBS), Reduced Representation Bisulfite Sequencing (RRBS), Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq), Chromatin Immunoprecipitation-Sequencing (ChIP-seq), TAB-seq (Tet-assisted Bisulfite Sequencing), Chromosome Conformation Capture Sequencing (3C-seq) and various of 3C-seq de-rivatives, DNase1-seq/MNase-seq/FAIRE-seqand RNA Sequencing (RNA-seq). These new techniques were used to iden-tify DNA methylation patterns and a broad range of protein/nucleic acid interactions, and to analyze chromatin conforma-tion.With these new technologies, researchers have gained a broader view and better tools to investigate the distributions and dynamic changes of epigenetic markers affected by both internal and external factors. The principles and characteristics of major applications of NGS technologies on epigenetics were summarized; and the recent advances and the future direc-tions in NGS-based epigenetic studies were further discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24846966

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  2 in total

1.  Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.

Authors:  Shunlin Liu; Xiaoying Chen; Ruhua Chen; Jinzhi Wang; Guoliang Zhu; Jianzhong Jiang; Hongwei Wang; Shiwei Duan; Jianan Huang
Journal:  Oncotarget       Date:  2017-05-30

Review 2.  Advances in single-cell sequencing and its application to musculoskeletal system research.

Authors:  Yongxiang Zhang; Jingkai Wang; Chao Yu; Kaishun Xia; Biao Yang; Yuang Zhang; Liwei Ying; Chenggui Wang; Xianpeng Huang; Qixin Chen; Li Shen; Fangcai Li; Chengzhen Liang
Journal:  Cell Prolif       Date:  2021-12-09       Impact factor: 6.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.